Work in a rat model of spontaneous hypertension (exhibits hypertension, insulin resistance and dyslipidemia, features of metabolic syndrome) showed that knocking out the CFB gene improved glucose tolerance and insulin sensitivity, with redistribution of visceral to subcutaneous fat. The gene discussed is INS; the disease is Hypertension.